Last CNY13.96 CNY
Change Today +0.06 / 0.43%
Volume 17.6M
As of 3:05 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
CNY14.00
Previous Close
CNY13.90
Day High
CNY14.03
Day Low
CNY13.77
52 Week High
10/14/13 - CNY17.10
52 Week Low
04/29/14 - CNY11.64
Market Cap
38.0B
Average Volume 10 Days
35.6M
EPS TTM
CNY0.88
Shares Outstanding
1.9B
EX-Date
05/26/14
P/E TM
15.8x
Dividend
CNY0.26
Dividend Yield
1.86%
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd. is engaged in the research and development, manufacture, distribution, and retail of pharmaceutical products in China and internationally. The company offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It also distributes vaccines and high-end consumables; and provides hospital service solutions focusing on the extended supply chain services, clinical supportive services, logistics, and information technology services. In addition, the company operates a chain of drugstores, pharmacies, joint-venture drugstores, DTP drugstores, etc. It has a strategic alliance with Shanghai Institute of Materia Medica. Shanghai Pharmaceuticals Holding Co., Ltd. was formerly known as Shanghai No. 4 Pharmaceutical Co., Ltd. The company was incorporated in 1994 and is based in Shanghai, China.

39,960 Employees
Last Reported Date: 08/27/14
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Employee Supervisor
Total Annual Compensation: --
Chairman of the Supervisory Board
Total Annual Compensation: --
Supervisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

Shanghai Pharmaceuticals Holding Co., Ltd. reported unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, the company reported revenue of RMB 44,013,016,000 compared to RMB 38,717,901,000 a year ago. Operating profit was RMB 1,741,970,000 compared to RMB 1,475,842,000 a year ago. Profit before income tax was RMB 1,917,104,000 compared to RMB 1,709,183,000 a year ago. Profit attributable to owners of the company was RMB 1,318,004,000 or RMB 0.4902 per basic and diluted share compared to RMB 1,189,609,000 or RMB 0.44 per basic and diluted share a year ago. Net cash used in operating activities was RMB 74,878,000 compared to net cash generated from operating activities of RMB 28,348,000 a year ago. Purchases of property, plant and equipment and investment properties were RMB 394,563,000 compared to RMB 413,146,000 a year ago. Closing net book amount 30 June 2014 was RMB 353,785,000 compared to RMB 313,553,000 a year ago. Weighted average return on net assets was 4.99%.

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Aug 27, 2014

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Aug 27, 2014. Agenda: To consider and approve semi-annual report of 2014 and its abstract; and to consider the proposal of formulating working measures of financially writing off provisions for assets impairment.

Shanghai Pharmaceuticals Holding Co., Ltd. Presents at Nomura China Investor Forum 2014, Sep-03-2014 02:30 PM

Shanghai Pharmaceuticals Holding Co., Ltd. Presents at Nomura China Investor Forum 2014, Sep-03-2014 02:30 PM. Venue: Pudong Shangri-la, The River Wing, Shanghai, China. Speakers: Di LU, the Board Office Senior Manager.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY13.96 CNY +0.06

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY60.30 CNY +2.42
Jointown Pharmaceutical Group Co Ltd CNY16.63 CNY +0.26
Nanjing Pharmaceutical Co Ltd CNY6.85 CNY -0.05
Wanjia Group Holdings Ltd $0.54 HKD 0.00
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 15.9x
Price/Sales 0.5x
Price/Book 1.4x
Price/Cash Flow 11.4x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.